Soligenix, Inc. (SNGX) earnings
SNGX earnings moved a median of -0.80% by the close. Quarterly and annual SNGX reports and results, each read against the price at its own news timestamp. Back to the SNGX overview →
21 measured SNGX earnings events.
Where these SNGX earnings landedvs 20 measured SNGX earnings reactions
| Middle 50% of SNGX earnings reactions | -3.62% to +1.03% |
|---|---|
| Median reaction (to close) | -0.80% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 SNGX earnings events with a measured close landed between -3.62% and +1.03%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q SOLIGENIX, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.00% | — | |
| Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results | Press release | +2.63% | +3.18% | |
| Form 10-Q SOLIGENIX, INC. For: Mar 31 | SEC filing · Form 10-Q | +1.41% | -3.41% | |
| Soligenix Announces Recent Updates and First Quarter 2026 Financial Results | Press release | -4.54% | -11.21% | |
| Form 10-K SOLIGENIX, INC. For: Dec 31 | SEC filing · Form 10-K | +0.53% | -4.96% | |
| Form 10-Q SOLIGENIX, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.70% | -4.22% | |
| Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results | Press release | -2.33% | +6.20% | |
| Form 10-Q SOLIGENIX, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.60% | -1.42% | |
| Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results | Press release | -0.59% | +15.29% | |
| Form 10-Q SOLIGENIX, INC. For: Mar 31 | SEC filing · Form 10-Q | -4.57% | -2.25% | |
| Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results | Press release | +0.00% | +1.54% | |
| Form 10-K SOLIGENIX, INC. For: Dec 31 | SEC filing · Form 10-K | +0.43% | -1.29% | |
| Form 10-Q SOLIGENIX, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.85% | +1.70% | |
| Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results | Press release | -0.58% | +0.86% | |
| Form 10-Q SOLIGENIX, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.30% | +0.33% | |
| Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results | Press release | +4.44% | -0.32% | |
| Form 10-Q SOLIGENIX, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.41% | |
| Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results | Press release | +0.40% | +0.13% | |
| Form 10-K SOLIGENIX, INC. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.93% | |
| Form 10-Q SOLIGENIX, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.27% | |
| Soligenix Announces Recent Accomplishments And Third Quarter 2023 Financial Results | Press release | +0.00% | -5.44% |
Keep exploring
More SNGX: analyst actions → · SEC filings → · SNGX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | 251 | +0.05% | 52% |
| Mersana Therapeutics, Inc. (MRSN) | 251 | -0.20% | 46% |
| Co-Diagnostics, Inc. (CODX) | 250 | 0.00% | 46% |
| argenx SE - American Depositary Shares (ARGX) | 249 | -0.02% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.